Nuuron
PrivateLast Round
Seed
Oct 31, 2024
Total Funding Raised
$3.81M
Company Overview
Nuuron is a neurotechnology company that develops the Memory-Pacemaker, a non-invasive, photonic neurostimulation device to re-enable patients with Alzheimer's Disease to store and recall memories.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials, Health IoT
Business Model
B2B2C
Customer Profile
Subscription SaaS, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nuuron Comparables
Compare Nuuron with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cognito Therapeutics | 83% | |
| Bottneuro AG | 78% | |
| OptoCeutics | 76% |
Nuuron Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 31, 2024 |
Key People
Founding team and executive leadership
Nuuron Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IBB Ventures | Seed |
Nuuron Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access